Mesenchymal Stem Cells (MSCs): A Novel Therapy for Type 2 Diabetes

Although plenty of drugs are currently available for type 2 diabetes mellitus (T2DM), a subset of patients still failed to restore normoglycemia. Recent studies proved that symptoms of T2DM patients who are unresponsive to conventional medications could be relieved with mesenchymal stem/stromal cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Shuang, Zhang, Yuanyuan, Liang, Kaini, Bi, Ran, Du, Yanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424025/
https://www.ncbi.nlm.nih.gov/pubmed/36045953
http://dx.doi.org/10.1155/2022/8637493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424025/
https://www.ncbi.nlm.nih.gov/pubmed/36045953
http://dx.doi.org/10.1155/2022/8637493

Ejemplares similares